Philips to stop selling sleep apnea machines in U.S. under tentative agreement with FDA, DOJ
Philips won't be able to sell new sleep apnea machines until it meets corrective actions laid out by the FDA.
WASHINGTON (AP) — The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under a tentative agreement with regulators that could cost the manufacturer nearly $400 million.
Device maker Philips has recalled more than 5 million pressurized breathing machines due to risks that their internal foam can break down over time, leading users to inhale tiny particles and fumes while they sleep.
What's Your Reaction?
